Veterinary Drugs Compounding Market, By Drug Class (CNS Agents, Anti-infective Agents, Hormones and Substitutes, Anti-inflammatory Agents, Others), By Animal Type (Companion Animals and Livestock Animals), By Formulation (Oral, Injectable, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jun 2024

Code : CMI4796

Pages :224

Formats :

Excel and PDF

Industry : Pharmaceutical

Market Challenges: Strict regulations surrounding drug compounding practices

The strict regulations surrounding drug compounding practices can hamper the market growth. Regulatory bodies have stringent rules around sterile and non-sterile preparation to ensure safety and efficacy. This raises production and compliance costs. The competition from commercialized therapeutic alternatives poses a threat, as large pharmaceutical companies engage in heavy R&D and marketing. Storage and distribution also present difficulties due to short shelf-lives of compounded medications and care needed in transportation.

Market Opportunities: Adoption of innovative drug delivery technologies

The adoption of innovative drug delivery technologies can offer new opportunities in the veterinary drugs compounding market. Novel technologies like transdermal gels, implants, and extended-release injections have the potential to significantly improve drug treatment for pets. These innovations allow for drugs to be efficiently delivered at consistent therapeutic levels over a prolonged period, thus, reducing the need for frequent dosing. This enhances compliance for pet owners and decreases stress for animals that often dislike ingesting conventional pills or visiting the vet regularly for injections.